Tavia Acquisition Corp.
For the period ended Dec 31, 2025. Filed Mar 16, 2026.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2025 · Filed Mar 16, 2026
TAVI$10.87+0.2%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Balance Sheets as of December 31, 2025 and 2024
BALANCE SHEETS
| December 31, | December 31, | |
|---|---|---|
| 2025 | 2024 | |
| Assets | ||
| Current assets | ||
| Cash and cash equivalents | $229,625 | $913,659 |
| Prepaid expenses | 131,850 | 44,059 |
| Total current assets | 361,475 | 957,718 |
| Marketable securities held in Trust Account | 120,754,293 | 115,926,937 |
| Total Assets | $121,115,768 | $116,884,655 |
| Liabilities, Ordinary Shares Subject to Possible Redemption, and Shareholders’ Equity (Deficit) | ||
| Current liabilities | ||
| Accrued offering costs | $75,000 | $85,000 |
| Accrued expenses | 708,156 | 72,448 |
| Advances from related party | 131,684 | 131,684 |
| Promissory note – related party | 500,000 | 500,000 |
| Total Liabilities | 1,414,840 | 789,132 |
| Commitments and Contingencies (Note 6) | ||
| Ordinary shares subject to possible redemption, 11,500,000 shares at redemption value of approximately $10.50 and $10.06 per share as of December 31, 2025 and 2024, respectively | 120,754,293 | 115,685,866 |
| Shareholders’ Equity (Deficit) | ||
| Preferred shares, $0.0001 par value; 100,000,000 shares authorized; none issued and outstanding | — | — |
| Ordinary shares, $0.0001 par value; 400,000,000 shares authorized; 4,420,833 shares issued and outstanding (excluding 11,500,000 subject to possible redemption) as of December 31, 2025 and 2024 | 442 | 442 |
| Additional paid-in capital | — | 329,697 |
| (Accumulated deficit) Retained earnings | (1,053,807) | 79,518 |
| Total Shareholders’ Equity (Deficit) | (1,053,365) | 409,657 |
| Total Liabilities, Ordinary Shares Subject to Possible Redemption, and Shareholders’ Equity (Deficit) | $121,115,768 | $116,884,655 |
STATEMENTS OF OPERATIONS
| For the Year Ended December 31, | For the Period from March 7, 2024 (inception) through December 31, | |
|---|---|---|
| 2025 | 2024 | |
| Formation, general and administrative expenses | $1,221,951 | $272,419 |
| Loss from operations | (1,221,951) | (272,419) |
| Other income: | ||
| Interest earned on marketable securities held in Trust Account | 4,827,356 | 351,937 |
| Total other income | 4,827,356 | 351,937 |
| Net income | $3,605,405 | $79,518 |
| Basic and diluted weighted average shares outstanding of redeemable ordinary shares | 11,500,000 | 1,015,000 |
| Basic and diluted net income per redeemable ordinary share | $0.23 | $0.01 |
| Basic and diluted weighted average shares outstanding of non-redeemable ordinary shares | 4,420,833 | 4,987,229 |
| Basic and diluted net income per non-redeemable ordinary share | $0.23 | $0.01 |
STATEMENTS OF CHANGES IN SHAREHOLDERS’ EQUITY (DEFICIT)
FOR THE YEAR ENDED DECEMBER 31, 2025 AND
FOR THE PERIOD FROM MARCH 7, 2024 (INCEPTION) THROUGH DECEMBER 31, 2024
| Ordinary Shares · Additional Paid-in · Retained · Total Shareholder’ Equity | |||||
|---|---|---|---|---|---|
| Shares | Amount | Capital | Earnings | (Deficit) | |
| Balance — March 7, 2024 (inception) | — | $— | $— | $— | $— |
| Issuance of ordinary shares to Sponsor | 3,833,333 | 383 | 24,617 | — | 25,000 |
| Issuance of ordinary shares to underwriters | 200,000 | 20 | 721,980 | — | 722,000 |
| Accretion for ordinary shares to redemption amount | — | — | (5,586,528) | — | (5,586,528) |
| Sale of Private Placement Units | 387,500 | 39 | 3,874,961 | — | 3,875,000 |
| Fair value of rights included in Public units | — | — | 1,380,000 | — | 1,380,000 |
| Allocated value of transaction costs to ordinary shares | — | — | (85,333) | — | (85,333) |
| Net income | — | — | — | 79,518 | 79,518 |
| Balance – December 31, 2024 | 4,420,833 | 442 | 329,697 | 79,518 | 409,657 |
| Accretion for ordinary shares to redemption amount | — | — | (329,697) | (4,738,730) | (5,068,427) |
| Net income | — | — | — | 3,605,405 | 3,605,405 |
| Balance – December 31, 2025 | 4,420,833 | $442 | $— | $(1,053,807) | $(1,053,365) |
STATEMENTS OF CASH FLOWS
| For the Year Ended December 31, | For the Period from March 7, 2024 (Inception) Through December 31, | |
|---|---|---|
| 2025 | 2024 | |
| Cash Flows from Operating Activities: | ||
| Net income | $3,605,405 | $79,518 |
| Adjustments to reconcile net income to net cash used in operating activities: | ||
| Payment of formation costs through issuance of founder shares | — | 5,000 |
| Payment of formation costs through promissory note | — | 3,027 |
| Payment of operation costs through promissory note | — | 161,728 |
| Interest earned on marketable securities held in Trust Account | (4,827,356) | (351,937) |
| Changes in operating assets and liabilities: | ||
| Prepaid expenses | (87,791) | (44,059) |
| Accrued expenses | 635,708 | 72,448 |
| Net cash used in operating activities | (674,034) | (74,275) |
| Cash Flows from Investing Activities: | ||
| Investment of cash into Trust Account | — | (115,575,000) |
| Net cash used in investing activities | — | (115,575,000) |
| Cash Flows from Financing Activities: | ||
| Proceeds from sale of Units, net of underwriting discounts paid | — | 112,700,000 |
| Proceeds from sale of Private Placement Units | — | 3,875,000 |
| Proceeds from advances from Sponsor | — | 131,684 |
| Proceeds from sale of founder shares | — | 994 |
| Proceeds from promissory note - related party | — | 231,209 |
| Repayment of promissory note - related party | — | (150,000) |
| Payment of offering costs | (10,000) | (225,953) |
| Net cash provided (used in) by financing activities | (10,000) | 116,562,934 |
| Net Change in Cash and Cash Equivalents | (684,034) | 913,659 |
| Cash and cash equivalents – Beginning of period | 913,659 | — |
| Cash and cash equivalents – End of period | $229,625 | $913,659 |
| Supplemental disclosure of cash flow information: | ||
| Offering costs included in accrued offering costs | $— | $85,000 |
| Deferred offering costs paid by Sponsor in exchange for issuance of Class B ordinary shares | $— | $742,000 |
| Deferred offering costs paid through promissory note – related party | $— | $254,036 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.